Northeast India’s Only English and Hindi Satellite News Channel

DRDO’s anti-COVID drug priced at Rs 990 per sachet; Centre, states to get discounts

First Published: 28th May, 2021 17:53 IST

Defence Research and Development Organisation’s (DRDO) anti-Covid-19 drug will be sold at Rs 990 per sachet by Dr Reddy’s Laboratories (DRL), officials said on Friday. The Hyderabad-based pharma company, however,

Defence Research and Development Organisation’s (DRDO) anti-Covid-19 drug will be sold at Rs 990 per sachet by Dr Reddy’s Laboratories (DRL), officials said on Friday. The Hyderabad-based pharma company, however, will provide the medicine to Centre and state government at a discounted price.

The first batch of DRDO’s anti-Covid-19 drug was released on May 17 by Defence Minister Rajnath Singh and health minister Dr Harsh Vardhan, after the Drugs Controller General of India permitted the emergency use authorisation of 2-deoxy-D-glucose (2-DG), anti-viral drug as an adjunct therapy for moderate to severe coronavirus patients.

In April last year when the pandemic broke out, scientists of Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO conducted laboratory experiments with the help of the Centre for Cellular and Molecular Biology (CCMB), Hyderabad in collaboration with DRL and found that this molecule works effectively against the SARS-CoV-2 virus and inhibits viral growth.

The 2-DG drug comes in powder form in the sachet, which is taken orally by dissolving it in water.

It accumulates in the virus-infected cells and prevents virus growth by stopping viral synthesis and energy production. Its selective accumulation in virally infected cells makes this drug unique.

The drug reportedly reduces a patient’s average recovery time by two and a half days and oxygen demand by upto 40 per cent, the Union Health Ministry said. (ANI)

COMMENTS

WE RECOMMEND

Banner
High turnout in Phase 1 of Lok Sabha Elections 2024 despite heat wave

The Commission led by CEC Rajiv Kumar and ECs Gyanesh Kumar and Sukhbir Singh Sandhu constantly monitored the progress of polling in Phase 1 across the constituencies from ECI Headquarters in Nirvachan Sadan.

19th April 2024
Banner
Lok Sabha elections 2024 Phase 1: Big faces and high-stakes battles

The candidature of its Tamil Nadu state president shows that the BJP is pressing hard to increase its presence in South India

19th April 2024
Banner
“You are not innocent”: SC tells Ramdev, he says will remain conscious in future

Co-founder of Patanjali Ayurved Ltd., Ramdev, tendered unconditional apology "for the mistakes", adding that "What we did at the time was not correct. We will be conscious about it in the future."

16th April 2024
Banner
Need skills to go far beyond Earth’s orbit: ISRO chief Somanath at Inter-Agency Space Debris Coordination Committee

The ISRO chief also issued a declaration saying that India aims to create debris free space missions by 2030.

16th April 2024
Banner
Five killed, several injured as bus falls from flyover in Odisha’s Jajpur

Chief District Medical Officer (CDMO) Shibasish Moharana said that out of 38 injured, one was seriously injured.

16th April 2024